These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 1377326)

  • 1. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
    Cascieri MA; Huang RR; Fong TM; Cheung AH; Sadowski S; Ber E; Strader CD
    Mol Pharmacol; 1992 Jun; 41(6):1096-9. PubMed ID: 1377326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
    Geraghty DP; Mussap CJ; Burcher E
    Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
    Gether U; Johansen TE; Schwartz TW
    J Biol Chem; 1993 Apr; 268(11):7893-8. PubMed ID: 7681831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor.
    Cascieri MA; Ber E; Fong TM; Sadowski S; Bansal A; Swain C; Seward E; Frances B; Burns D; Strader CD
    Mol Pharmacol; 1992 Sep; 42(3):458-63. PubMed ID: 1383685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
    Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
    Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R; Barthó L; Maggi CA
    Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
    Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
    Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the novel ligand [4,5-3H-Leu10]substance P to high-affinity NK-1 receptors on guinea pig lung membranes: modulation by GTP analogs and sulfhydryl modifying agents.
    Aharony D; Catanese CA; Woodhouse DP
    J Pharmacol Exp Ther; 1991 Oct; 259(1):146-55. PubMed ID: 1717678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
    Ciucci A; Palma C; Manzini S; Werge TM
    Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells.
    Ingi T; Kitajima Y; Minamitake Y; Nakanishi S
    J Pharmacol Exp Ther; 1991 Dec; 259(3):968-75. PubMed ID: 1662278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
    Burcher E; Buck SH; Lovenberg W; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
    Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of tachykinin-induced intracellular calcium rise in a human NK2 receptor transfected cell line.
    Subramanian N; Ruesch C; Bertrand C
    Biochem Biophys Res Commun; 1994 May; 200(3):1512-20. PubMed ID: 8185607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the cloned human NK3 receptor in Chinese Hamster Ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer.
    Jordan RE; Smart D; Grimson P; Suman-Chauhan N; McKnight AT
    Br J Pharmacol; 1998 Oct; 125(4):761-6. PubMed ID: 9831912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptor.
    Perrine SA; Beard DJ; Young JK; Simmons MA
    Eur J Pharmacol; 2008 Sep; 592(1-3):1-6. PubMed ID: 18634782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the substance P receptor antagonist RP 67580 with the rat brain NK1 receptor expressed in transfected CHO cells.
    Hermans E; Jeanjean AP; Fardin V; Pradier L; Garret C; Laduron PM; Octave JN; Maloteaux JM
    Eur J Pharmacol; 1993 Mar; 245(1):43-50. PubMed ID: 7682962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.